Position：Home >Chinese Medicines>Xeligekimab>Xeligekimab Drug News
Xeligekimab
Xeligekimab

Xeligekimab(赛立奇单抗注射液)

As China's first domestically developed fully human anti-IL-17A targeted biological product, Serelizumab Injection is characterized by rapid onset of action, long-lasting efficacy and favorable safety profile.

  • 1mg/prefilled syringe

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.
Authentic
Guarantee
Fast Delivery
Privacy

Xeligekimab Drug News

Recommended

There is no data in this category！

Copyright 2024 @ haiouhealth.com All right reserved Seagull health | Bigbear Pharmaceutical | Lucius Pharmaceuticals | 老挝全球药房

whatsAppIcon

Order on WhatsApp